Concepts (150)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Multiple Sclerosis | 11 | 2023 | 3222 | 2.150 |
Why?
|
| Fatigue | 8 | 2021 | 1551 | 2.030 |
Why?
|
| Avoidance Learning | 3 | 2015 | 248 | 1.280 |
Why?
|
| Neuropeptides | 4 | 2016 | 944 | 1.050 |
Why?
|
| Neurotransmitter Agents | 5 | 2016 | 665 | 0.980 |
Why?
|
| Elasticity Imaging Techniques | 3 | 2022 | 392 | 0.790 |
Why?
|
| Ghrelin | 2 | 2013 | 252 | 0.760 |
Why?
|
| Anxiety | 5 | 2017 | 4571 | 0.760 |
Why?
|
| Nicotine | 4 | 2018 | 680 | 0.750 |
Why?
|
| Medial Forebrain Bundle | 1 | 2021 | 43 | 0.740 |
Why?
|
| Oligopeptides | 3 | 2015 | 1186 | 0.740 |
Why?
|
| Anti-Anxiety Agents | 1 | 2023 | 397 | 0.700 |
Why?
|
| Receptors, Opioid | 2 | 2014 | 145 | 0.560 |
Why?
|
| Rats, Wistar | 10 | 2021 | 1846 | 0.560 |
Why?
|
| Dopamine | 3 | 2018 | 1605 | 0.540 |
Why?
|
| Receptors, GABA-A | 2 | 2016 | 623 | 0.470 |
Why?
|
| Opioid Peptides | 1 | 2014 | 37 | 0.470 |
Why?
|
| Urocortins | 4 | 2021 | 19 | 0.460 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2014 | 2870 | 0.450 |
Why?
|
| Brain | 10 | 2023 | 27103 | 0.420 |
Why?
|
| Phenoxybenzamine | 3 | 2016 | 53 | 0.380 |
Why?
|
| General Surgery | 1 | 2022 | 1692 | 0.360 |
Why?
|
| Corticotropin-Releasing Hormone | 5 | 2021 | 361 | 0.350 |
Why?
|
| Receptors, Corticotropin-Releasing Hormone | 3 | 2021 | 89 | 0.330 |
Why?
|
| Haloperidol | 3 | 2016 | 389 | 0.330 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2021 | 2790 | 0.320 |
Why?
|
| Amygdala | 2 | 2013 | 1353 | 0.310 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2016 | 1249 | 0.310 |
Why?
|
| Corpus Striatum | 2 | 2018 | 1235 | 0.300 |
Why?
|
| Radiology | 1 | 2022 | 2113 | 0.300 |
Why?
|
| Interleukin-1beta | 1 | 2013 | 997 | 0.300 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2014 | 1140 | 0.290 |
Why?
|
| Behavior, Animal | 1 | 2014 | 1878 | 0.260 |
Why?
|
| Fever | 1 | 2013 | 1618 | 0.260 |
Why?
|
| Depression | 3 | 2021 | 8122 | 0.260 |
Why?
|
| Bicuculline | 2 | 2016 | 96 | 0.250 |
Why?
|
| Atrophy | 3 | 2020 | 1632 | 0.250 |
Why?
|
| Atropine | 2 | 2016 | 244 | 0.240 |
Why?
|
| Peptide Fragments | 3 | 2021 | 5114 | 0.220 |
Why?
|
| Propranolol | 2 | 2016 | 489 | 0.220 |
Why?
|
| Dopamine Antagonists | 2 | 2014 | 288 | 0.220 |
Why?
|
| Antidepressive Agents | 1 | 2014 | 2897 | 0.200 |
Why?
|
| Rats | 9 | 2021 | 23729 | 0.200 |
Why?
|
| Internship and Residency | 1 | 2022 | 5877 | 0.190 |
Why?
|
| Multiple Sclerosis, Relapsing-Remitting | 2 | 2017 | 555 | 0.190 |
Why?
|
| Magnetic Resonance Imaging | 13 | 2023 | 36430 | 0.190 |
Why?
|
| Corticosterone | 4 | 2016 | 305 | 0.190 |
Why?
|
| Alzheimer Disease | 1 | 2022 | 8592 | 0.180 |
Why?
|
| Animals | 19 | 2022 | 168388 | 0.170 |
Why?
|
| Acetylcholine | 1 | 2021 | 628 | 0.160 |
Why?
|
| Pituitary-Adrenal System | 4 | 2016 | 551 | 0.160 |
Why?
|
| Hypothalamus | 2 | 2013 | 999 | 0.150 |
Why?
|
| Aquaporin 4 | 1 | 2019 | 161 | 0.150 |
Why?
|
| Hypothalamo-Hypophyseal System | 4 | 2016 | 700 | 0.150 |
Why?
|
| Plaque, Amyloid | 1 | 2022 | 759 | 0.150 |
Why?
|
| Cross-Sectional Studies | 4 | 2023 | 26108 | 0.140 |
Why?
|
| Male | 22 | 2023 | 360621 | 0.140 |
Why?
|
| Anisotropy | 1 | 2021 | 1283 | 0.140 |
Why?
|
| Oropharyngeal Neoplasms | 1 | 2023 | 491 | 0.140 |
Why?
|
| Methysergide | 1 | 2016 | 28 | 0.140 |
Why?
|
| Cyproheptadine | 1 | 2016 | 19 | 0.140 |
Why?
|
| Substance Withdrawal Syndrome | 2 | 2018 | 625 | 0.120 |
Why?
|
| Mice | 8 | 2022 | 81474 | 0.120 |
Why?
|
| Neuromyelitis Optica | 1 | 2019 | 263 | 0.120 |
Why?
|
| Adrenocorticotropic Hormone | 2 | 2013 | 617 | 0.120 |
Why?
|
| Immobility Response, Tonic | 1 | 2014 | 13 | 0.120 |
Why?
|
| Adrenergic alpha-1 Receptor Antagonists | 1 | 2014 | 24 | 0.120 |
Why?
|
| Prazosin | 1 | 2014 | 95 | 0.120 |
Why?
|
| Serotonin Agents | 1 | 2014 | 29 | 0.120 |
Why?
|
| Adrenergic Antagonists | 1 | 2014 | 26 | 0.120 |
Why?
|
| GABA-A Receptor Antagonists | 1 | 2014 | 60 | 0.120 |
Why?
|
| Receptors, Adrenergic, alpha | 1 | 2014 | 146 | 0.120 |
Why?
|
| Adrenergic alpha-Antagonists | 1 | 2014 | 174 | 0.110 |
Why?
|
| Receptors, Ghrelin | 1 | 2013 | 20 | 0.110 |
Why?
|
| Mecamylamine | 1 | 2013 | 27 | 0.110 |
Why?
|
| Glioblastoma | 2 | 2020 | 3482 | 0.110 |
Why?
|
| Receptors, Dopamine D3 | 1 | 2014 | 108 | 0.110 |
Why?
|
| Receptors, Dopamine D4 | 1 | 2014 | 170 | 0.110 |
Why?
|
| Injections, Intraventricular | 1 | 2013 | 225 | 0.110 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 2014 | 241 | 0.110 |
Why?
|
| Swimming | 1 | 2014 | 208 | 0.110 |
Why?
|
| Maze Learning | 1 | 2014 | 482 | 0.100 |
Why?
|
| Disease Models, Animal | 4 | 2022 | 18234 | 0.100 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2014 | 10764 | 0.100 |
Why?
|
| Receptors, Dopamine D2 | 1 | 2014 | 485 | 0.100 |
Why?
|
| Meningeal Neoplasms | 1 | 2020 | 1248 | 0.100 |
Why?
|
| Nitric Oxide Synthase | 1 | 2014 | 906 | 0.090 |
Why?
|
| Psychotropic Drugs | 1 | 2016 | 888 | 0.090 |
Why?
|
| Papillomavirus Infections | 1 | 2023 | 1610 | 0.090 |
Why?
|
| Tobacco Use Disorder | 1 | 2016 | 703 | 0.090 |
Why?
|
| Body Temperature | 1 | 2013 | 782 | 0.090 |
Why?
|
| Humans | 17 | 2023 | 761326 | 0.090 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2020 | 2047 | 0.090 |
Why?
|
| Receptors, Nicotinic | 1 | 2013 | 495 | 0.090 |
Why?
|
| Education, Medical, Graduate | 1 | 2022 | 2373 | 0.080 |
Why?
|
| Mice, Transgenic | 1 | 2022 | 9534 | 0.080 |
Why?
|
| Narcotic Antagonists | 1 | 2014 | 585 | 0.080 |
Why?
|
| Curriculum | 1 | 2022 | 3741 | 0.080 |
Why?
|
| Head and Neck Neoplasms | 1 | 2023 | 2891 | 0.080 |
Why?
|
| Internet | 1 | 2020 | 3094 | 0.080 |
Why?
|
| Hippocampus | 1 | 2021 | 3763 | 0.080 |
Why?
|
| Middle Aged | 8 | 2023 | 220774 | 0.080 |
Why?
|
| Synaptic Transmission | 1 | 2014 | 1172 | 0.070 |
Why?
|
| Brain Neoplasms | 2 | 2020 | 9030 | 0.070 |
Why?
|
| Female | 10 | 2023 | 392485 | 0.070 |
Why?
|
| Adult | 7 | 2021 | 221122 | 0.070 |
Why?
|
| Clinical Competence | 1 | 2022 | 4793 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 2 | 2022 | 22154 | 0.070 |
Why?
|
| Longitudinal Studies | 2 | 2020 | 14597 | 0.060 |
Why?
|
| Memory | 1 | 2014 | 2187 | 0.060 |
Why?
|
| Locomotion | 2 | 2018 | 388 | 0.060 |
Why?
|
| Thalamus | 2 | 2021 | 1044 | 0.060 |
Why?
|
| Brain Mapping | 1 | 2019 | 6626 | 0.060 |
Why?
|
| Prefrontal Cortex | 1 | 2013 | 2219 | 0.050 |
Why?
|
| Mice, Nude | 2 | 2020 | 3603 | 0.050 |
Why?
|
| Disease Progression | 2 | 2017 | 13500 | 0.050 |
Why?
|
| Amyloid beta-Peptides | 1 | 2015 | 3836 | 0.050 |
Why?
|
| Amino Acid Sequence | 1 | 2013 | 13446 | 0.050 |
Why?
|
| Stroke | 1 | 2023 | 9749 | 0.050 |
Why?
|
| Molecular Sequence Data | 1 | 2013 | 17640 | 0.050 |
Why?
|
| Retrospective Studies | 4 | 2023 | 80575 | 0.050 |
Why?
|
| Reproducibility of Results | 3 | 2023 | 20092 | 0.040 |
Why?
|
| Forelimb | 1 | 2019 | 116 | 0.040 |
Why?
|
| Motor Activity | 2 | 2018 | 2710 | 0.040 |
Why?
|
| Viscosity | 1 | 2017 | 336 | 0.040 |
Why?
|
| Infusions, Intraventricular | 1 | 2016 | 32 | 0.030 |
Why?
|
| Hindlimb | 1 | 2019 | 512 | 0.030 |
Why?
|
| Memory, Short-Term | 1 | 2023 | 982 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2021 | 54405 | 0.030 |
Why?
|
| Elasticity | 1 | 2017 | 655 | 0.030 |
Why?
|
| Acoustic Stimulation | 1 | 2019 | 1235 | 0.030 |
Why?
|
| Nicotinic Agonists | 1 | 2016 | 265 | 0.030 |
Why?
|
| Eliminative Behavior, Animal | 1 | 2013 | 1 | 0.030 |
Why?
|
| Electric Stimulation | 1 | 2019 | 1735 | 0.030 |
Why?
|
| Receptors, Corticotropin | 1 | 2013 | 24 | 0.030 |
Why?
|
| Arginine Vasopressin | 1 | 2013 | 125 | 0.030 |
Why?
|
| Myelin Sheath | 1 | 2017 | 653 | 0.030 |
Why?
|
| Body Temperature Regulation | 1 | 2013 | 292 | 0.020 |
Why?
|
| Antibodies | 1 | 2020 | 2421 | 0.020 |
Why?
|
| Lymph Nodes | 1 | 2023 | 3469 | 0.020 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2016 | 1337 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2020 | 3489 | 0.020 |
Why?
|
| Phantoms, Imaging | 1 | 2017 | 2524 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2023 | 11098 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2017 | 16966 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2023 | 20555 | 0.010 |
Why?
|
| Time Factors | 1 | 2017 | 39974 | 0.010 |
Why?
|
| Prognosis | 1 | 2016 | 29588 | 0.010 |
Why?
|
| Aged | 2 | 2017 | 169179 | 0.010 |
Why?
|
| Young Adult | 1 | 2017 | 59196 | 0.010 |
Why?
|
Concepts
(150)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(34)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_